Yombi, Jean Cyr
[UCL]
Marot, J.C.
De Visscher, N.
Ausselet, Nathalie
[UCL]
Vincent, André
[UCL]
Vandercam, Bernard
[UCL]
Co-infection HIV/HCV or HBV is frequent because of the common ways of transmission of these various viruses. HIV-infected patients are living longer since the introduction of highly active antiretroviral therapy. However, co-infection with the hepatitis C virus (HCV) or hepatitis B virus leads to increased morbidity from liver disease and higher overall mortality. Noxious interactions between these viruses are currently well-known in particular acceleration by the HIV of the natural history of HCV or HBV infection. Recent progress was made in the diagnosis and management of the patients Co-infected by HIV/HCV or HBV Although remarkable, this progress does not occult the need for continuing the preventive measures to reduce the acquisition of new infections and the development of new drugs more effective and better-tolerated to ensure a more important therapeutic success for all the Co-infected patients.
Bibliographic reference |
Yombi, Jean Cyr ; Marot, J.C. ; De Visscher, N. ; Ausselet, Nathalie ; Vincent, André ; et. al. La co-infection par le virus de l'immunodéficience humaine (VIH) et le virus de l'hépatite C (VHC) ou le virus de l'hépatite B (VHB). In: Louvain Medical, Vol. 126, no. 7, p. 238-248 (2007) |
Permanent URL |
http://hdl.handle.net/2078.1/164702 |